Most Australians first heard about RNA during the COVID pandemic. But scientists believe that was only the beginning.

Sean Aylmer speaks with Paul McDonald, CEO of RNA Australia, about the technology that's already transforming medicine and could soon play a major role in treating cancer, rare diseases, respiratory illnesses and biosecurity threats. McDonald explains how RNA therapies work, why Australia has traditionally struggled to commercialise world-class research, and how a new end-to-end RNA manufacturing facility aims to keep Australian discoveries in Australia.